Response of human dendritic cells to different immunomodulatory polysaccharides derived from mushroom and barley

International Immunology

Volumn 19, Issue 7, 2007, Pages 891-899

  Chan, Wing Keung ^a   Law, Helen Ka Wai ^a   Lin, Zhi Bin ^b   Lau, Yu Lung ^a   Chan, Godfrey Chi Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Barley; Ganoderma lucidum; Human dendritic cell; Immunomodulation; Polysaccharides

Indexed keywords

BARLEY EXTRACT; GANODERMA LUCIDUM EXTRACT; GLUCAN; INTERLEUKIN 10; INTERLEUKIN 12; PLANT EXTRACT; POLYSACCHARIDE; UNCLASSIFIED DRUG;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; BARLEY; CELL MATURATION; CELL POLARITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG POTENCY; GANODERMA LUCIDUM; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOSTIMULATION; IN VITRO STUDY; MUSHROOM; MYCELIUM; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PURIFICATION; REGULATORY T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ANTIGENS, CD4; CELL PROLIFERATION; CELLS, CULTURED; DENDRITIC CELLS; ENDOCYTOSIS; HORDEUM; HUMANS; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LEUKOCYTES, MONONUCLEAR; LYMPHOTOXIN-ALPHA; POLYSACCHARIDES; REISHI; T-LYMPHOCYTES;

EID: 34547838395     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm061     Document Type: Article

References (32)

1. Borchers, A. T., Keen, C. L. and Gershwin, M. E. 2004. Mushrooms, tumors, and immunity: An update. Exp. Biol. Med. (Maywood) 229:393.
2. Chang, R. 2002. Bioactive polysaccharides from traditional Chinese medicine herbs as anticancer adjuvants. J. Altern. Complement. Med. 8:559.
3. Ooi, V. E. and Liu, F. 2000. Immunomodulation and anti-cancer activity of polysaccharide-protein complexes. Curr. Med. Chem. 7:715.
4. Wasser, S. P. and Weis, A. L. 1999. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: A modern perspective. Crit. Rev. Immunol. 19:65.
5. Lin, Z. B. and Zhang, H. N. 2004. Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol. Sin. 25:1387.
6. Lin, Z. 2001. Lingzhi De Xiandai Yanjiu. Beijing Medical University Press, Beijing.
7. Bao, X., Liu, C., Fang, J. and Li, X. 2001. Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydr. Res. 332:67.
8. Bohn, J. and BeMiller, J. 1995. (1->3)-β-Glucans as biological response modifiers: A review of structure-functional activity relationships. Carbohydr. Polym. 28:3.
9. Cheung, N. K., Modak, S., Vickers, A. and Knuckles, B. 2002. Orally administered beta-glucans enhance anti-tumor effects of monoclonal antibodies. Cancer Immunol. Immunother. 51:557.
10. Hong, F., Yan, J., Baran, J. T. et al. 2004. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J. Immunol. 173:797.
11. Cheung, N. K. and Modak, S. 2002. Oral (1->3),(1->4)-beta-D-glucan synergizes with antiganglioside GD2 monoclonal antibody 3F8 in the therapy of neuroblastoma. Clin. Cancer Res. 8:1217.
12. Banchereau, J. and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245.
13. Steinman, R. M. 2001. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation. Mt. Sinai J. Med. 68:106.
14. Morisaki, T., Matsumoto, K., Onishi, H. et al. 2003. Dendritic cellbased combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: Rationale, current progress, and perspectives. Hum. Cell. 16:175.
15. Hasebe, H., Nagayama, H., Sato, K. et al. 2000. Dysfunctional regulation of the development of monocyte-derived dendritic cells in cancer patients. Biomed. Pharmacother. 54:291.
16. Whiteside, T. L., Stanson, J., Shurin, M. R. and Ferrone, S. 2004. Antigen-processing machinery in human dendritic cells: Up-regulation by maturation and down-regulation by tumor cells. J. Immunol. 173:1526.
17. Song, S. Y. and Kim, H. S. 2004. Strategies to improve dendritic cell-based immunotherapy against cancer. Yonsei Med. J. (Suppl. 45)48.
18. Schuler-Thurner, B., Schultz, E. S., Berger, T. G. et al. 2002. Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J. Exp. Med. 195:1279.
19. Smits, H. H., de Jong, E. C., Wierenga, E. A. and Kapsenberg, M. L. 2005. Different faces of regulatory DCs in homeostasis and immunity. Trends Immunol. 26:123.
20. Akira, S. 2004. Toll receptor families: Structure and function. Semin. Immunol. 16:1.
21. Brown, G. D., Herre, J., Williams, D. L., Willment, J. A., Marshall, A. S. and Gordon, S. 2003. Dectin-1 mediates the biological effects of beta-glucans. J. Exp. Med. 197:1119.
22. Herre, J., Willment, J. A., Gordon, S. and Brown, G. D. 2004. The role of dectin-1 in antifungal immunity. Crit. Rev. Immunol. 24:193.
23. Taylor, P. R., Brown, G. D., Reid, D. M. et al. 2002. The beta-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169:3876.
24. Cao, L. Z. and Lin, Z. B. 2002. Regulation on maturation and function of dendritic cells by Ganoderma lucidum polysaccharides. Immunol. Lett. 83:163.
25. Cao, L. Z. and Lin, Z. B. 2003. Regulatory effect of Ganoderma lucidum polysaccharides on cytotoxic T-lymphocytes induced by dendritic cells in vitro. Acta Pharmacol. Sin. 24:321.
26. Chan, W. K., Lam, D. T. W., Law, H. K. W. et al. 2003. Ganoderma lucidum mycelium and spore extracts as natural adjuvant for immunotherapy. J. Alter. Complemen. Med. 11:1047.
27. Lin, S.,Wang, S., Lin, Z. and Lin, Y. 2003. Isolation and identification of active components of Ganoderma lucidum cultivated with grass and wood log. Extraction, purification and characterization of glycopeptide. Chinese Traditional and Herbal Drugs 34:872.
28. Jonuleit, H. and Schmitt, E. 2003. The regulatory T cell family: distinct subsets and their interrelations. J. Immunol. 171:6323.
29. Shiao, M. S. 2003. Natural products of the medicinal fungus Ganoderma lucidum: Occurrence, biological activities, and pharmacological functions. Chem. Rec. 3:172.
30. Hsu, H. Y., Hua, K. F., Lin, C. C., Lin, C. H., Hsu, J. and Wong, C. H. 2004. Extract of Reishi polysaccharides induces cytokine expression via TLR4-modulated protein kinase signaling pathways. J. Immunol. 173:5989.
31. Shao, B. M., Dai, H., Xu, W., Lin, Z. B. and Gao, X. M. 2004. Immune receptors for polysaccharides from Ganoderma lucidum. Biochem. Biophys. Res. Commun. 323:133.
32. Meyer-Wentrup, F., Cambi, A., Adema, G. J. and Figdor, C. G. 2005. "Sweet talk": Closing in on C type lectin signaling. Immunity 22:399.